Kimberly-Clark Acquisition of Safeskin Completed

Article

Safeskin Shareholders Approve Transaction

DALLAS, TX-The acquisition agreement signed in November 1999 between Kimberly-Clark Corporation and Safeskin Corporation has been approved by Safeskin shareholders. By approving the merger, Safeskin shareholders gave Kimberly-Clark entrance to the latex and synthetic glove market. Chairman and chief executive officer of Kimberly-Clark, Wayne R. Sanders, commented, "Safeskin has built one of the fastest growing, most technologically innovative and cost-effective businesses in the glove industry. We are pleased to complement our expanding offering of professional healthcare products with Safeskin gloves. With this acquisition, we will be able to offer a complete line of head-to-toe protection products for healthcare workers."

Valued at $800 million, the transaction includes issuing Safeskin shareholders .1956 of a share of Kimberly-Clark common stock for each share of Safeskin common stock. David R. Murray, president of Kimberly-Clark's professional healthcare sector will assume leadership of the Safeskin line and Richard Jaffe, chairman, president and chief executive officer of Safeskin will become a company consultant.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.
 Futuristic UV Sanitizer with Sleek Design on a white background.  (Adobe Stock 1375983522 by Napa)